{"organizations": [], "uuid": "fc0dcd70ba82ae0d2ee027b1cb7283ee1e7b3986", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-radius-health-initiates-phase-3-tr/brief-radius-health-initiates-phase-3-trial-of-abaloparatide-injection-for-male-osteoporosis-idUSASC09UD2", "country": "US", "domain_rank": 408, "title": "BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-30T21:34:00.000+03:00", "replies_count": 0, "uuid": "fc0dcd70ba82ae0d2ee027b1cb7283ee1e7b3986"}, "author": "", "url": "https://www.reuters.com/article/brief-radius-health-initiates-phase-3-tr/brief-radius-health-initiates-phase-3-trial-of-abaloparatide-injection-for-male-osteoporosis-idUSASC09UD2", "ord_in_thread": 0, "title": "BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis", "locations": [], "entities": {"persons": [{"name": "abal", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "brief-radius health initiates phase", "sentiment": "negative"}, {"name": "injection for male osteoporosis reuters staff", "sentiment": "none"}, {"name": "reuters) - radius health inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 30, 2018 / 6:35 PM / Updated an hour ago BRIEF-Radius Health Initiates Phase 3 Trial Of Abaloparatide Injection For Male Osteoporosis Reuters Staff 1 Min Read \nMarch 30 (Reuters) - Radius Health Inc: \n* RADIUS HEALTH INITIATES PHASE 3 CLINICAL TRIAL OF ABALOPARATIDE INJECTION FOR THE TREATMENT OF MALE OSTEOPOROSIS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-30T21:34:00.000+03:00", "crawled": "2018-03-30T21:47:47.094+03:00", "highlightTitle": ""}